EUVIMEDEUVIMED entdecken
Crossref

The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2. mdx mouse model of Duchenne muscular dystrophy

Catherine A Bellissimo iD, Shivam Gandhi, Laura N Castellani, Mayoorey Murugathasan, Luca J Delfinis, Arshdeep Thuhan, Madison C Garibotti, Yeji Seo, Irena A Rebalka, Henry H Hsu, Gary Sweeney iD, Thomas J Hawke iD und 2 weitere

American Journal of Physiology-Cell Physiology · 2024

DOI: 10.1152/ajpcell.00638.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Catherine A Bellissimo und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Kinesiology & Health Science, Muscle Health Research Centre, York University, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Gouvernement du Canada | Canadian Institutes of Health Research (IRSC), Mitacs (Mitacs Canada).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are limited therapies for the treatment of Duchenne muscular dystrophy. As fibrosis involves an accumulation of collagen that replaces muscle fibers, antifibrotics may help preserve muscle function. We report that the novel adiponectin receptor agonist ALY688-SR prevents fibrosis in the diaphragm of D2. mdx mice with short-term treatment early in disease progression. These responses were related to altered inflammation and mitochondrial functions and serve as a foundation for the development of this class of therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneAnimalsMiceMice, Inbred mdxAdiponectinDisease Models, AnimalInterleukin-6Mice, Inbred C57BLHydrogen PeroxideReceptors, AdiponectinMice, Inbred DBAMuscle, SkeletalDiaphragmFibrosisInflammationDisease ProgressionAtrophy

Stichwörter der Autor:innen

atrophydystrophinfibrosismitochondriamuscle

Substanzen

AdiponectinInterleukin-6Hydrogen PeroxideReceptors, Adiponectin

Autor:innen und Institutionen

  • School of Kinesiology & Health Science, Muscle Health Research Centre, York University, Toronto, Ontario, Canada.
  • Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Allysta Pharmaceuticals Inc, Bellevue, Washington, United States.
  • Department of Biology, Muscle Health Research Centre, York University, Toronto, Ontario, Canada.

ORCID-Profile: Catherine A Bellissimo, Gary Sweeney, Thomas J Hawke, Ali A Abdul-Sater, Christopher G R Perry

Förderung

  • Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)
  • Mitacs (Mitacs Canada)
  • Allysta Pharmaceuticals
  • Canada Foundation for Innovation (CFI)

Zitieren

APA

Bellissimo, C. A., Gandhi, S., Castellani, L. N., Murugathasan, M., Delfinis, L. J., Thuhan, A., Garibotti, M. C., Seo, Y., Rebalka, I. A., Hsu, H. H., Sweeney, G., Hawke, T. J., Abdul-Sater, A. A., & Perry, C. G. R. (2024). The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2. mdx mouse model of Duchenne muscular dystrophy. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00638.2023

Vancouver

Bellissimo CA, Gandhi S, Castellani LN, Murugathasan M, Delfinis LJ, Thuhan A, et al. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2. mdx mouse model of Duchenne muscular dystrophy. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00638.2023

BibTeX
@article{Bellissimo2024,
  author = {Bellissimo, Catherine A and Gandhi, Shivam and Castellani, Laura N and Murugathasan, Mayoorey and Delfinis, Luca J and Thuhan, Arshdeep and Garibotti, Madison C and Seo, Yeji and Rebalka, Irena A and Hsu, Henry H and Sweeney, Gary and Hawke, Thomas J and Abdul-Sater, Ali A and Perry, Christopher G R},
  title = {The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2. mdx mouse model of Duchenne muscular dystrophy},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2024},
  doi = {10.1152/ajpcell.00638.2023}
}
Kostenlos starten →